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ABSTRACT 
The herb Evolvulus nummularius (L). L generally grown as an ornamental plant has found many applications in traditional folk 
medicine. There was however insufficient scientific data to back its safety to be used on humans. Methanolic extract of E. 
nummularius was used to check for its safety as a vaginal microbicide through various safety tests such as cell viability using MTT 
assay on three female genital tract epithelial cell lines, vaginal (VK2/E6E7), endocervical (End1/E6E7) and endometrial (HEC-1-A). 
Quantification of hemolytic activity was done on human red blood cells (RBCs). Determination of cellular integrity was checked by 
transepithelial electrical resistance (TER) assay and permeability by fluorescent microsphere assay. At 24 hours, application of the 
extract for cell viability assay showed extensive cell death with cell disruption. IC50 of VK2/E6E7 and HEC-1-A cells were found to 
be 2 mg/ml, IC50of End1/E6E7 was 1 mg/ml. For hemolytic assay, with treatment of the extract for one hour did not show hemolysis 
till the concentration of 2.5mg/ml. In TER and microsphere permeability assays, polarized HEC-1-A monolayer 24 hours post 
treatment had significant drop in TER and enhanced fluorescence from passage of microspheres implying disruption of the epithelial 
monolayer. The study revealed that the crude methanolic extract appeared to be toxic towards human RBCs and female genital tract 
epithelial cells. Due to its toxic nature, its direct applications to the human vaginal tissue in vivo should be done with caution. 
Keywords: Medicinal plants; Microbicide; Evolvulus nummularius (L). L; MTT assay; Transepithelial electrical resistance; 
Fluorescent microsphere assay. 
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INTRODUCTION 
Before synthetic drugs became popular, medicines were 
obtained from natural sources such as plants, animals 
and microbes. Herbal medicines have passed down 
through ages being considered as safe. Even today plant 
parts are eaten, used for cosmetic purpose and as 
medicines without proper knowledge if they are toxic. 
As per WHO estimates at present 65-80% of the world 
population relies on herbal medicines
1
. It is naive to 
consider however, that since these plants have been 
consumed as food or are being used as herbal products 
they are safe. As per the review of Lanini et al.
2
 “if 
herbs have an effect, they are also likely to have a side 
effect”. The toxicity or safety of any substance derived 
from nature depends on several factors such as its route 
of administration, dosage and period of time the 
medicine is active. In most countries plant based 
medicines are sold as dietary supplements and therefore 
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safety and regulatory studies essential for drugs have 
never been applied for many a medicinal plant. 
Evolvulus nummularius (L). L (Syn. Convolvulus 
nummularius L., L.) though generally grown as an 
ornamental plant, has found many applications in 
traditional folk medicines to cure burns, cuts, hysteria, 
scorpion stings
3
. In Nepal, its paste has been used to 
treat scabies.
4
 It is also known to possess wound healing 
properties.
5
 Study dating back to 1964 revealed 
anticonvulsant and sedative properties in E. 
nummularius.
6
 A paste made of E. nummularius along 
with other plants is used in the treatment of peptic 
ulcer.
7 
The herb is also known to be applied to legs to 
reduce edema during pregnancy.
8 
Activity of E. 
nummularius against standard Gram-positive and 
negative bacteria has been reported by Pavithra, 
Sreevidya and Verma.
9 
Dash et al.
10
 reported its 
antihelminthic activity, and Saha, Dinda, and Sil
11 
reported its activity against parasite Leishmania 
donovani. 
Since the plant has shown extensive medicinal 
properties, we intended to test its usefulness as a vaginal 
microbicide against sexually transmitted pathogens. 
There was however insufficient scientific data to back 
its safety to be used on human tissues. E. nummularius 
therefore was found to be an interesting candidate 
requiring detailed safety studies both for application as a 
microbicide, as well as to know the safety of its 
application for its reported other medicinal activities. 
MATERIALS AND METHODS 
Plant collection and authentication 
Fresh whole plants including roots of E. nummularius 
were collected from the Tripura University campus at 
Suryamaninagar, Agartala, Tripura, India. The plant was 
initially identified by Prof. B. K. Datta, Taxonomist, 
Department of Botany, TU and finally authenticated by 
Dr. H. J. Chowdhery, Joint Director, Central National 
Herbarium, Botanical Survey of India, Shibpur, 
Howrah, West Bengal and voucher specimen No. (#BD-
05/05) was deposited in the Central National Herbarium, 
Botanical Garden, Shibpur, Howrah, West Bengal, 
India. 
Preparation of extract 
Collected whole plants including roots were washed and 
air dried for three weeks. They were then ground and 5 
kilo grams of ground plant parts were macerated with 15 
liters of methanol for 48 hrs. The extract was then 
filtered and evaporated in a rotary evaporator (Hahn 
Shin Scientific Corporation, South Korea). At the end of 
this the extracts were left to air dry for a week at 4°C to 
remove more traces of the solvent. Finally, methanolic 
extract of E. nummularius (MEEN) was dissolved in 
double distilled water at a stock concentration of 100 
mg/ml. 
Cell lines and cultural conditions 
VK2/E6E7 and End1/E6E7 two keratinocyte cell lines 
developed from vaginal and endocervical tissues 
respectively were kind gifts from Dr. Fichorova. HEC-
1-A cell line established from human endometrial 
adenocarcinoma
12 
was procured from National Center 
for Cell Science, Pune, India. VK2/E6E7 and 
End1/E6E7 cell lines were maintained in keratinocyte 
serum-free medium and HEC-1-A was cultured in 
McCoy’s 5A (modified) medium13. 
Determination of cell viability using MTT assay 
Cell viability was determined using MTT {3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide} 
as per previous protocol of Sathe and Reddy.
14
 Briefly, 
VK2/E6E7, End1/E6E7 were incubated in 100 µL 
KSFM and HEC-1-A cells in 100 µL McCoy in 96-well 
plates for 24 hrs. Then, 100 µL from 24 mg/ml stock 
concentration of plant extract was added in row A. The 
200 µL of solution (100 µL drug + 100 µL media) were 
mixed and 100 µL from row A were added into next row 
(row B) by using micropipette and a serial dilution was 
done up to row G. Finally, excessive 100 µL from row 
G were discarded. The final volume for each well was 
100 µL. As a positive control for cytotoxicity, 10 µL of 
0.1% Triton X-100 (TX) was added. An untreated 
negative control (UT) well with only cells and media 
was also included. At the end of the 24 hrs treatment 
time point cells were washed thrice with PBS (pH 7.2). 
MTT (0.5 mg/ml) was added next for 3 hrs at 37°C, 
following which cells were morphologically observed 
for analyzing changes induced by the extracts. Cells in 
each well were then solubilized in 100 µL dimethyl 
sulfoxide (DMSO). Reduction of MTT to formazan 
crystals within cells was quantified by measuring optical 
density at 570 nm using Synergy H1 microplate reader 
(BioTek Instruments) and percentage cell viability 
calculated as percentage of average absorbance of 
duplicate drug wells divided by average absorbance of 
control wells. IC50 was calculated as per the protocol of 
Vijayarathna and Sasidharan.
15
 
Determination of transepithelial electrical resistance 
(TER) 
In vitro determination of cellular integrity was done 
through TER measurement of HEC-1-A cell monolayer 
as per the protocol of Sathe and Reddy.
14 
HEC-1-A cell 
line was used to prepare cell monolayer. 200 µL and 900 
µL of McCoy media with supplements were added in 
the apical and basal compartments respectively and 
changed every alternate day. Transwell inserts were 
cultured at 37°C in a humidified atmosphere of 5% CO2 
for 7- 8 days until confluent monolayer of HEC-1-A 
cells were formed. TER (Millicell ERS Ohmmeter, 
Millipore) of the established polarized monolayer was 
measured daily till the 8
th
 day. The net TER was 
calculated by subtracting the background and 
multiplying the resistance by the area (1.12 cm
2
) of the 
filter. Upon formation of confluent monolayer on the 8
th
 
day, HEC-1-A cells were treated with the extract. Each 
Transwell insert was subjected to one treatment: 
untreated control (UT), MEEN (T-En1.0) at a 
concentration of 1 mg/ml, and positive control for 
cytotoxicity treated with 0.1% Triton X-100 (TX). The 
treatments were given for 24 hrs, post which TER was 
measured to observe for any drop in resistance. 
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Fluorescent microsphere assay 
Permeability assay using fluorescent microspheres of 
the size of HIV virus particles was done as per the 
protocol of Gali et al.
16 
To the polarized HEC-1-A cell 
monolayers set up in Transwell units upon reaching 
confluency, treatments were divided into three groups: 
untreated control (UT), MEEN (T-En1.0) in 
concentration of 1 mg/ml, and positive cell death 
induced by 0.1% Triton X-100 (TX). Yellow green 
fluorescent microspheres of diameter 0.1 µm were then 
added in the volume of 100 µL (approx. 1.8 x 
10
4
 beads). Post treatment for 24 hrs, 200 µL of media 
from the basal chamber was harvested and fluorescence 
was measured at 486 nm. Fluorescence emitted by beads 
that crossed the treated monolayer as compared to the no 
treatment control with intact monolayer was plotted as 
percentage fluorescence and level of significance 
analyzed. 
Hemolytic assay 
5 mL of fresh human red blood cells (HRBCs) was 
obtained from a healthy donor in a polycarbonate tube 
containing heparin. The hemolytic activity of MEEN 
was evaluated as described previously.
17 
The release of 
hemoglobin after 1 hour of incubation was measured 
by monitoring optical density at 576 nm. Untreated 
HRBC suspension was used as a negative control (UT), 
and the HRBCs treated with 0.1% Triton X-100 (TX) 
was employed as a control positive to bring about 
hemolysis. Percent hemolysis was calculated using the 
equation given below and the concentration of extract 
which caused 10% hemolysis was taken as the minimum 
hemolytic concentration. 
 
Hemolysis (%) =  O.D.576nm of the treated sample – O.D.576nm of the negative control)      x 100 
                                      (O.D.576nm of the positive hemolysis inducer – O.D.576nm of the negative control) 
 
Statistical analysis 
All data were calculated as the mean value ± standard 
deviation (SD) from three independent experiments 
performed on different days. The significant effect of 
each treatment with respect to untreated control was 
carried out through t test at various significance levels 
(*p < 0.05; ** p < 0.01). 
RESULTS 
Determination of cell viability by MTT Assay 
The effects on viability of three cell lines after treatment 
with MEEN were assessed through the MTT assay. 
Multiple concentrations of MEEN were used and the 
results of percentage viability at each concentration are 
as shown in Table 1. Dose-response curve was plotted 
against each concentration to enable the calculation of 
the concentrations that kill 50% of the cells (IC50) as 
shown in Fig. 1. MEEN showed cell viability in the 
range of 34% - 54%, and its IC50 was determined to be 2 
mg/ml for VK2/E6E7 and HEC-1-A cell lines and 1 
mg/ml for End1/E6E7 cell line. 
Fig. 2 shows microscopic observations of VK2/E6E7 
cells with various treatment post MTT assay. 
 
Table 1: Viability assay of vaginal, endocervical and endometrial cell lines after 24 hrs treatment with MEEN as 
determined through MTT assay. Absorbance was measured at 570 nm. Values are calculated as mean ± SD of three 
independent experimental trials. 
Concentration of 
MEEN (mg/ml) 
Absorbance (Mean ± SD) Viability (%) 
VK2/E6E7 End1/E6E7 HEC1A VK2/E6E7 End1/E6E7 HEC1A 
1.00 0.292 ± 0.03 0.239 ± 0.06 0.289 ± 0.01 51.14% 50.05% 54.12% 
2.00 0.286 ± 0.01 0.238 ± 0.01 0.28 ± 0.03 50.03% 49.89% 52.46% 
3.00 0.276 ± 0.01 0.215 ± 0.03 0.264 ± 0.01 48.29% 45.17% 49.38% 
6.00 0.225 ± 0.07 0.2 ± 0.02 0.252 ± 0.01 39.37% 41.88% 47.14% 
12.00 0.195 ± 0.01 0.173 ± 0.02 0.25 ± 0.02 34.15% 36.24% 46.90% 
Untreated 0.571 ± 0.02 0.477 ± 0.02 0.534 ± 0.03 100% 100% 100% 
Triton X-100 0.111 ± 0.03 0.05 ± 0.03 0.095 ± 0.04 19.37% 10.46% 17.78% 
IC50 (mg/ml) 2.00 1.00 2.00 
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Figure 1: Effect of MEEN on the viability of vaginal, endocervical and endometrial epithelial cell lines as tested 
through MTT assay after 24 hrs of treatment. Percentage viability of cells in presence of various concentrations of 
MEEN was measured after 24 hours of treatment. Values are calculated as mean ± SD of three independent 
experimental trials where each condition was tested in duplicate. 
 
Figure 2a 
 
Figure 2b 
 
Figure 2c 
 
Figure 2: Microscopic observation of viability of vaginal epithelial cell line (VK2/E6E7) as tested through MTT 
assay after 24 hrs of treatment. (a) Untreated control, (b) MEEN (1 mg/ml), (c) Positive control of cytotoxicity (0.1% 
Triton X-100) (Magnification: 20X; Scale: 100 µm). When compared to untreated control, MEEN and Triton X-100 
treated cells can be seen to have shrunken, rounded cells with lot of cell debris and ruptured cell membrane, formazan 
crystal formations are also rarely observed. 
 
Determination of transepithelial electrical resistance 
By growing HEC-1-A cells on Transwell inserts, a 
polarized epithelial cell monolayer with both apical and 
basolateral compartments was established (Table 2). On 
day 8
th
,
 
confluent monolayer of HEC-1A cells were 
treated with various treatments for 24 hrs and changes in 
TER values in comparison to a known cell death inducer 
(0.1% Triton X-100) were determined. In this test as 
well MEEN at a concentration of 1.0 mg/ml (T-En1.0) 
showed significant (p < 0.01) reduction in TER values, 
comparable to the cell death inducer, indicating 
considerable cell death and monolayer disruption. Fig. 
3a and 3b. shows the recording of TER values as the 
confluency increased and effect on TER values post 
treatment.
 
Table 2: Time dependent effect of MEEN on transepithelial electrical resistance (TER) on HEC-1-A cell 
monolayer. Monolayer integrity was measured through changes in TER values upon treatment with plant extracts. 
Values are calculated as mean ± SD of three independent experimental trials. 
 Resistance (Ω/cm2) (Mean ± SD) 
Treatments UT T-En1.0 TX 
Time (days) Day 1 32.67 ± 8.39  30.33 ± 5.03 32.67 ± 3.21 
Day 2 39.00 ± 2.00  37.67 ± 4.51 44.00 ± 3.61 
Day 3 44.00 ± 3.00 60.00 ± 7.21 70.67 ± 2.52 
Day 4 61.33 ± 4.04 72.33 ± 2.08 71.00 ± 2.65 
Day 5 67.33 ± 2.52 76.67 ± 5.69 74.33 ± 4.04 
Day 6 70.67 ± 4.51 82.00 ± 6.56 75.67 ± 5.86 
Day 7 85.67 ± 1.53 83.67 ± 2.52 85.33 ± 3.51 
Day 8 (before treatment) 93.67 ± 5.13 98.00 ± 4.00 91.33 ± 4.04 
Day 9 (after treatment) 92.67 ± 3.06 73.33 ± 5.13 47.00 ± 2.00 
UT, Untreated; T-En1.0, MEEN (1mg/ml); TX, 0.1% Triton X-100.The significant effect of each treatment as compared to untreated 
control was carried out through t test at significance level (*** p < 0.01). 
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Figure 3a 
 
Figure 3b 
 
Figure 3: Time dependent effect of MEEN on transepithelial electrical resistance (TER) of HEC-1-A cell 
monolayer. a) TER values as measured on a daily basis till the 8
th
 day when monolayer was formed and TER values 
peaked. On 8
th
 day treatments were given and on 9
th
 day (24 hrs) TER values were noted again to check for any drop in 
values signifying disruption of monolayer integrity. b) Comparison of TER values between untreated and treated 
groups on 9
th
 day. Values are calculated as mean ± SD of three independent experimental trials. The significant effect 
of each treatment as compared to untreated control was carried out through t test at significance level (*** p < 0.01). 
UT, Untreated; T- En1.0, MEEN (1mg/ml); TX, 0.1% Triton X-100 
 
Permeability of fluorescent microspheres 
Enhanced fluorescence was observed for the background 
well containing media only without cell and cell death 
inducer 0.1% Triton X-100, indicating TX to have 
extensively disrupted the confluent monolayer formed 
by HEC-1-A cells. As seen in Fig. 4, percentage 
fluorescence resulting from passage of fluorescently 
labeled microspheres at the 24 hour treatment time point 
were 29% for MEEN, indicating significant (p < 0.01) 
disruption in cellular integrity. 
 
 
Basu Mullick et al                                                                                            Journal of Drug Delivery & Therapeutics. 2018; 8(4):229-236           
ISSN: 2250-1177                                                                             [234]                                                                             CODEN (USA): JDDTAO 
 
Figure 4: Graphical representation showing 
percentage fluorescence measured in the basal 
media due to permeation of fluorescent 
microsphere beads across polarized HEC-1-A 
monolayer. Values are calculated as mean ± SD of 
three independent experimental trials. The significant 
effect of each treatment as compared to untreated 
control was carried out through t test at significance 
level (*** p < 0.01). 
UT, Untreated; T- En1.0, MEEN (1mg/ml); TX, 0.1% 
Triton X-100 
 
Hemolytic activity of MEEN 
Hemolytic activity of MEEN against HRBCs was 
evaluated at serial concentrations in the range of 0.1–20 
mg/ml (Fig. 5). MEEN showed no hemolytic activity in 
the range of 0.1–2.5 mg/ml, on the other hand at higher 
concentrations of 5–20 mg/ml MEEN showed 
considerable hemolysis in the 19%–31% range. 
Minimum hemolytic concentration that caused 10% 
hemolysis of HRBCs was determined to be 5.0 mg/ml 
for MEEN (Table 3 & Fig. 6).  
Table 3: Determination of Minimum hemolytic 
concentration. The concentration of MEEN which 
caused 10% hemolysis in human RBCs was taken as the 
minimum hemolytic concentration.  
Concentration of extract (mg/ml) % Hemolytic 
0.1 0% ± 0.00 
0.2 0% ± 0.00 
0.3 0% ± 0.00 
0.6 0% ± 0.00 
1.2 0% ± 0.00 
2.5 0% ± 0.00 
5 19.25% ± 0.03* 
10 28.92% ± 0.02 
20 31.47% ± 0.06 
Untreated 0% ± 0.00 
0.1% Triton X-100 100% ± 0.00 
*Minimum hemolytic concentration 
 
 
Figure 5: Effect of MEEN in inducing hemolysis in 
human RBCs. Values are calculated as mean ± SD of 
three independent experimental trials. 
 
Figure 6: Effect of MEEN treatment on hemolysis of 
human RBCs. 1. Untreated control, 2. MEEN (2.5 
mg/ml), 3. MEEN (5 mg/ml), 4. MEEN (10 mg/ml). 
Hemolysis was observed in the 3
rd
 and 4
th
 MEEN treated 
tubes as can be seen through diffused RBC pellets. 
DISCUSSION 
The study was undertaken with the aim of developing a 
microbicide from the herb Evolvulus nummularius, 
which is well-known for its medicinal properties.
3-11 
Since safety study is an essential early step in preclinical 
microbicide development, the safety of the methanolic 
crude extract of E. nummularius (MEEN) was tested in 
this paper. 
For a future microbicidal candidate to be successful, in 
vitro results should mimic future in vivo results. For this 
reason a logical step is to select such cell types for 
cytotoxicity tests which are most likely to be involved 
during in vivo infection cycles. Since the exact 
mechanism of infection is still a mystery for most STI 
pathogens and also because an ideal microbicidal 
candidate is required to be effective against more than 
one STI pathogen, it is best to test the candidate 
compound on a variety of cell types focusing on those 
known to be targets for in vivo infection. Hence, vaginal 
(VK2/E6E7), endocervical (End1/E6E7) and 
endometrial (HEC-1-A) cell lines were chosen, which 
will likely be involved in in vivo infection cycles
18 
and 
are the target cells for developing a vaginal microbicide. 
A microbicide for optimal activity needs to be applied 
frequently over a long period of time and it is essential 
that the compound does not cause abrasion or 
inflammation to the host tissue. Therefore cell viability 
assay using MTT assay on vaginal epithelial cell lines 
and a hemolytic assay on human RBCs were performed. 
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Following MTT treatment, after a period of 24 hrs with 
MEEN at concentration range of 1 mg/ml – 12 mg/ml, 
microscopic observation showed extensive cell death 
with cell disruption, breakage of cell to cell adhesion 
and very few intracellular formazan crystals. While the 
IC50 of VK2/E6E7 and HEC-1-A cells were 2 mg/ml, 
IC50 of End1/E6E7 was even lower at 1 mg/ml. Cell 
mortality was comparable to the commonly used 
cytotoxic compound Triton X-100. In the hemolytic 
assay, after treating with MEEN for one hour, MEEN 
did not show hemolysis till the concentration of 2.5 
mg/ml. However at higher concentrations ranging from 
5 mg/ml to 20 mg/ml 20% to 30% hemolysis were 
observed. 
In TER and microsphere permeability assays, polarized 
HEC-1-A monolayer were set up in dual chamber 
Transwell units mimicking the in vivo epithelial barrier. 
Also mimicking natural infection by STI causing 
pathogens were the fluorescent microspheres used in the 
permeability assay which were of 100 nm diameter, a 
dimension similar to that of HIV- 1 virus particles. As 
would be done in the application of a microbicide, 
MEEN was applied onto the apical side only for 24 
hours. A significant drop in electrical resistance as 
measured through TER and enhanced fluorescence from 
passage of microspheres from the apical to the basal 
chamber compared to the control well implied cell 
death, which in in vivo system would translate to 
disruption of the epithelial layer and passage of STI 
pathogens. 
Although several plant extracts may have medicinal 
value, their therapeutic potential is known to depend on 
various other factors. Secondary metabolites can cause 
toxicity to cells at concentrations demonstrating 
inhibition of bacterial growth. In this study, 
phytochemical analysis of E. nummularius was found to 
contain saponins, triterpenoids and cardiac glycosides in 
high concentrations. Saponins and triterpenoids have 
both been studied to have cytotoxic effect. The presence 
of saponins which if present in high concentration may 
disrupt cellular membranes and cause cellular toxicity 
and hemolysis.
19 
Triterpenoids in several studies have 
shown specific toxicity towards cancer cell lines,
20 
however, in certain studies they have shown cytotoxicity 
to normal cells of the human body too.
21-23
 
Drawbacks of this study and studies in general  on plant 
extracts  as microbicidal study candidates are batch to 
batch variations on presence of secondary metabolites 
which may be due to season of collection, phenological 
age of the plant, climatic and abiotic factors. Future 
studies therefore should focus on methods to identify the 
pure compound responsible for its antimicrobial activity, 
which can avoid such problems as batch to batch 
variations, and also pure compounds can be expected to 
be effective at much lower concentrations. 
CONCLUSION 
In conclusion, though we started out with the aim of 
developing a microbicide from the plant E. nummularius 
whose medicinal properties have been well documented, 
in vitro safety studies showed the methanolic extract of 
the plant to be highly toxic towards human red blood 
cells and female genital tract epithelial cells. E. 
nummularius extract has many applications in folk 
medicine. Due to its highly toxic nature, its applications 
where applied directly to the human epithelium such as 
to treat burns and cuts,
3 
as a treatment for scabies when 
applied as a paste,
4
 as a wound healing compound,
5 
and 
as a paste to treat peptic ulcer
7 
should be done with 
extreme caution and safety studies should be conducted 
using appropriate cell types. 
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